Related Experiment Video

Updated: Apr 21, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

7.8K

DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity

Sinyi Kong1, Muthusamy Thiruppathi2, Quan Qiu1

  • 1Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611;

Journal of Immunology (Baltimore, Md. : 1950)
|November 2, 2014
PubMed

Insights

Deletion of DBC1 gene enhances B cell activation via CD40 and BAFF signaling, boosting antibody production. This discovery reveals DBC1 as a key regulator of B cell responses and autoimmune disease susceptibility.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • CD40 and BAFFR signaling are crucial for B cell proliferation and immunoglobulin (Ig) production.
  • Dysregulated B cell activation contributes to autoimmune diseases.

Purpose of the Study:

  • To investigate the role of DBC1 (Deleted in Breast Cancer 1) in regulating B cell activation.
  • To elucidate the molecular mechanisms by which DBC1 influences CD40 and BAFFR signaling pathways.

Main Methods:

  • Utilized Dbc1 gene-deficient (Dbc1(-/-)) mice and wild-type littermates.
  • Performed in vitro stimulation assays (CD40, BAFF, BCR, LPS).
  • Conducted microarray analysis and chromatin immunoprecipitation (ChIP) assays.
  • Immunized mice and assessed B cell populations and antigen-specific Ig levels.
  • Evaluated susceptibility to experimental autoimmune myasthenia gravis.

Main Results:

  • Dbc1(-/-) B cells exhibited elevated proliferation and Ig (IgG1, IgA) production upon CD40 and BAFF stimulation.
  • DBC1 was found to suppress the transcriptional activity of alternative NF-κB members (RelB and p52) downstream of CD40 signaling.
  • Dbc1(-/-) mice showed increased germinal center B cells, plasma cells, and antigen-specific Ig levels post-immunization.
  • Loss of DBC1 conferred higher susceptibility to experimental autoimmune myasthenia gravis.

Conclusions:

  • DBC1 acts as a cell-intrinsic inhibitor of CD40/BAFF-mediated B cell activation.
  • DBC1 regulates B cell function by suppressing the alternative NF-κB pathway.
  • DBC1 is a novel regulator of B cell responses with implications for autoimmune pathogenesis.

More Related Videos

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

9.9K
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.2K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.3K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
6.8K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.0K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.1K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
10.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.0K